AstraZeneca in the United States
For the Health of America
Nearly 18,000 employees – approximately 20% of our global team — spanning 23 R&D, manufacturing, commercial and corporate sites across 11 states, Washington, DC and Puerto Rico
12 manufacturing and supply sites across 9 states and Puerto Rico, supported by 3,150 manufacturing employees
Two of six global strategic R&D centers are based in the US – one in Gaithersburg, MD and one in Cambridge, MA
At AstraZeneca, we are trailblazers on a bold mission to transform healthcare through breakthrough science and life-changing medicines. By partnering across sectors and investing in American innovation, we’re building a stronger, more resilient US healthcare system—one that delivers faster diagnoses, greater access, and better outcomes for all.
We are reinforcing our commitment to the US with a $50 billion investment by 2030 to expand R&D and manufacturing, accelerating innovation for patients. This investment reflects our confidence in American innovation and our next-generation therapies, and our commitment to improving the nation’s health.
